Come up with a name for your new list and we'll add to it:
Lanthio Pharma raised a round of funding on May 21, 2014. Investors include
Rijksdienst voor Ondernemend Nederland.
Lanthio Pharma is a biopharmaceutical company committed to developing and commercializing therapeutic peptides against difficult to target receptors (e.g. GPCRs). With its proprietary LanthioPep techn…